Adaptive Biotechnologies (ADPT) Minority Interest (2021 - 2026)

Adaptive Biotechnologies has disclosed Minority Interest across 6 years of filings, most recently posting $7.7 million for Q2 2026.

• In Q2 2026, Minority Interest rose 4380.66% year-over-year to $7.7 million; the TTM figure through Jun 2026 stood at $7.7 million (up 4380.66% YoY), while the FY2025 annual figure was $6.2 million, up 2871.43% from the prior year.
• Minority Interest came in at $7.7 million for Q2 2026 at Adaptive Biotechnologies, down from $7.9 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $7.9 million in Q1 2026 to a low of -$224000.0 in Q4 2024.
• Average Minority Interest over 5 years is $1.1 million, with a median of -$82000.0 recorded in 2023.
• Year-over-year, Minority Interest sank 675.0% in 2023 and jumped 4380.66% in 2026.
• Over 5 years, Minority Interest stood at -$67000.0 in 2022, then slumped by 80.6% to -$121000.0 in 2023, then plunged by 85.12% to -$224000.0 in 2024, then soared by 2871.43% to $6.2 million in 2025, then increased by 24.81% to $7.7 million in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were $7.7 million in Q2 2026, $7.9 million in Q1 2026, and $6.2 million in Q4 2025.